Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion type Assertion NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_head.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion wasGeneratedBy ECO_0000203 NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_provenance.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion wasDerivedFrom befree-2016 NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_provenance.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion SIO_000772 15886296 NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_provenance.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion evidence source_evidence_literature NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_provenance.
- NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_assertion description "[Therapy-related acute myeloid leukemia/myelodysplastic syndrome (tAML/MDS) is an exception, and MSI is frequent in tAML/MDS following cancer chemotherapy or organ transplantation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494180.RAC7S4gF5CCe0mG682ME3uIXJoGX_6HBtNNugEYEeQ99I130_provenance.